Stock screener

NXGL

Conviction 0HealthcareScan · Thu, Jun 25, 2026
NXGL$0.5124-5.13%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
4
2
Vol MA14 620.1K
Mar 26Apr 14May 1May 19Jun 8Jun 25
NEXGEL, INC.SURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.nexgel.com ↗
Price0.5124
Change-5.13%
Gap-1.87%
Rel volume0.37×
Avg volume450.61K
Avg $ vol260.77K
SMA 200.5707
SMA 500.5876
SMA 2001.41
Price vs 50-12.80%
Price vs 200-63.61%
MA stackbearish
50/200 cross—
Supertrenddown · 0.6898
RSI (14)42
MACD hist-0.00
MACD crossbear · 0d
Stoch %K / %D13 / 14
ADX (14)26
+DI / −DI22 / 16
RSI divergence—
MACD divergence—
ATR %+11.84%
ADR %9.37%
52w high2.78
52w low0.5100
From 52w high-81.57%
Above 52w low+0.47%
New 52w highNo
SqueezeOn · 26d
Bollinger width19.10%
%B-0.03
Donchian pos13.44%
Donchian high0.6889
Donchian low0.4850
AVWAP (52w high)0.9164
vs AVWAP high-44.09%
AVWAP (52w low)0.5811
vs AVWAP low-11.83%
OBV trendFlat
Chaikin MF (20)-0.23
Today vs 20d0.37×
Avg vol (14d)620.1K
Avg vol (20d)450.61K
Avg $ vol (20d)260.77K
Market cap4.68M
RS 3m (vs SPY)-33.05%
RS 6m (vs SPY)-74.40%
RS line new highNo
Trend template0/8
Technical rank7.1
1 week-16.14%
1 month-2.59%
3 months-24.12%
6 months-67.36%
1 year-78.29%
YTD-71.69%
P/E-1.56
P/B1.17
P/S0.41
P/FCF-3.39
EPS-0.3800
Div yield—
ROE-75.11%
ROA-25.87%
Debt/Eq0.23
Current1.70
EV/EBITDA-1.60
Gross margin39.48%
Net margin-26.27%
Rev growth31.46%
EPS growth8.56%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value4.65M
Revenue2.65M
Net income-927K
Gross profit1.06M
Free cash flow-1.38M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out9.23M
Employees19
ListedWed, Dec 22, 2021
Free float6.25M
Float %76.8%
Short interest106.69K
Days to cover0.6d
Short volume5.7%
Squeeze score7 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank7.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.6694
Support0.5030
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NXGL

All disclosures →
No recent disclosed trades by Congress in NXGL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NXGL · 4 buys · 6 sells

InsiderSideShares
Levy Adam R.
Chief Executive Officer · Common Stock · 2026-06-08
Sell3K
Levy Adam R.
Chief Executive Officer · Common Stock · 2026-06-04
Sell3K
Levy Adam R.
Chief Executive Officer · Common Stock · 2026-06-01
Sell2K
Levy Adam R.
Chief Executive Officer · Common Stock · 2026-05-29
Sell3K
Levy Adam R.
Chief Executive Officer · Common Stock · 2026-05-28
Sell7K
Levy Adam R.
Chief Executive Officer · Common Stock · 2026-05-27
Sell3K
Henry Scott Robert
Director · Warrant to Purchase Common Stock (the "Warrant") · 2026-05-14
Buy20.83K
Henry Scott Robert
Director · Convertible Promissory Note (the "Note") · 2026-05-14
Buy41.67K
Levy Adam R.
Chief Executive Officer · Convertible Promissory Note (the "Note") · 2026-05-14
Buy100K
Levy Adam R.
Chief Executive Officer · Warrant to Purchase Common Stock (the "Warrant") · 2026-05-14
Buy50K

SEC filings

EDGAR filings in NXGL · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.